Genera Biosystems Ltd (GBI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
December 2018
30
About the Report
About the Report
Summary
Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is a molecular diagnostic test for the detection and genotyping of high risk and low risk types of human papillomavirus that cause cervical cancer or genital warts. GBL uses AmpaSand beads technology to create identifiable clusters of beads that can be distinguished in a conventional flow cytometer. The company provides products to detect influenzaA, influenzaB, influenza A H1N1, influenzaA H5N1, respiratory syncytial virus, human metapneumovirus, adenovirus, rhinovirus, bordetella pertussis, and chlamydophila pneumonia. It collaborates with pathology customers and IVD companies. GBL is headquartered in Melbourne, Victoria, Australia.
Genera Biosystems Ltd (GBI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Genera Biosystems Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Genera Biosystems Announces Private Placement of Shares for USD0.5 Million 11
Genera Biosystems Completes Private Placement Of Shares For USD 0.12 Million 12
Genera Biosystems Raises USD1.01 Million in Rights Issue Of Shares 13
Debt Offering 14
Genera Biosystems Completes Private Placement of Notes for USD0.3 Million 14
Genera Biosystems Raises USD0.2 Million in Private Placement of Notes Due 2015 15
Genera Biosystems Completes Private Placement Of Notes Due 2015 For USD 0.34 Million 16
Genera Biosystems Ltd-Key Competitors 17
Genera Biosystems Ltd-Key Employees 18
Genera Biosystems Ltd-Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Nov 01, 2018: Genera Biosystems: Quarterly cash flow & business update for 30th June 2018 20
Corporate Communications 21
Nov 30, 2018: Genera Biosystems: changes to the board of directors 21
Other Significant Developments 22
May 01, 2018: Genera Biosystems:Quarterly Cash Flow & Business Update 22
Nov 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update 23
Jul 31, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update 24
May 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update for the period ended 31 March 2017 26
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30
List of Figure
List of Figures
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genera Biosystems Announces Private Placement of Shares for USD0.5 Million 11
Genera Biosystems Completes Private Placement Of Shares For USD 0.12 Million 12
Genera Biosystems Raises USD1.01 Million in Rights Issue Of Shares 13
Genera Biosystems Completes Private Placement of Notes for USD0.3 Million 14
Genera Biosystems Raises USD0.2 Million in Private Placement of Notes Due 2015 15
Genera Biosystems Completes Private Placement Of Notes Due 2015 For USD 0.34 Million 16
Genera Biosystems Ltd, Key Competitors 17
Genera Biosystems Ltd, Key Employees 18
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.